Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous SVF for Knee Osteoarthritis
NCT04050111Phase 2Unknown
- Sponsor
- Swiss Medica
- Start
- Aug 2019
- Primary completion
- Feb 2021
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of autologous adipose-derived stromal vascular fraction in knee osteoarthritis (OA), sponsored by Swiss Medica. Status: unknown.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04050111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050111.